Philip Scheltens

MedicineNeuroscience

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 2%percentile

3.5Author DataRank

Indexed papers

5in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 5 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Association of amyloid-β CSF/PET discordance and tau load 5 years later

Neurology(2020)10.1212/wnl.0000000000010739

Top 11%

1.9DataRank

Top 11%53 citations

Lyduine E. Collij, Philip Scheltens, Femke H. Bouwman, Rik Ossenkoppele, for the Alzheimer's Disease Neuroimaging Initiative +1 more

Papers

Driven by 44 papers — median percentile 79. Top paper: “Revised criteria for the diagnosis and staging of Alzheimer’s disease”.

Revised criteria for the diagnosis and staging of Alzheimer’s disease

Nature Medicine(2024)10.1038/s41591-024-02988-7

N/A

3.5DataRank · unranked

167 citations

Scott J. Andrews, Thomas G. Beach, Teresa Buracchio, Billy Dunn, Ana Graf +15 more

Association of amyloid-β CSF/PET discordance and tau load 5 years later

Neurology(2020)10.1212/wnl.0000000000010739

Top 11%

1.9DataRank

Top 11%53 citations

Lyduine E. Collij, Philip Scheltens, Femke H. Bouwman, Rik Ossenkoppele, for the Alzheimer's Disease Neuroimaging Initiative +1 more

Investigating the clinico-anatomical dissociation in the behavioral variant of Alzheimer disease

Alzheimer s Research & Therapy(2020)10.1186/s13195-020-00717-z

Top 21%

0.950DataRank

Top 21%23 citations

Yolande A.L. Pijnenburg, Carole H. Sudre, Colin Groot, Elena Kochova, Frederik Barkhof +10 more

World‐Wide FINGERS Network: A global approach to risk reduction and prevention of dementia

Alzheimer s & Dementia(2020)10.1002/alz.12123

N/A

0.942DataRank · unranked

532 citations

Francesca Mangialasche, Heather M. Snyder, Ricardo Allegri, Sandrine Andrieu, Hidenori Arai +64 more

Association of Rare APOE Missense Variants V236E and R251G With Risk of Alzheimer Disease

JAMA Neurology(2022)10.1001/jamaneurol.2022.1166

N/A

0.681DataRank · unranked

93 citations

Michaël E. Belloy, Benjamin Grenier‐Boley, Itziar de Rojas, Atahualpa Castillo-Morales, Iris E. Jansen +95 more

Differential trajectories of hypometabolism across cognitively-defined Alzheimer’s disease subgroups

NeuroImage Clinical(2021)10.1016/j.nicl.2021.102725

Top 31%

0.642DataRank

Top 31%18 citations

Shannon L. Risacher, J.Q. Alida Chen, Ellen Dicks, Andrew J. Saykin, Christine L. Mac Donald +9 more

Amyloid-driven disruption of default mode network connectivity in cognitively healthy individuals

Brain Communications(2021)10.1093/braincomms/fcab201

N/A

0.617DataRank · unranked

60 citations

Jori Tomassen, Viktor Wottschel, Naomi Prent, Dennis van ‘t Ent, Mara ten Kate +12 more

The case for regulatory approval of amyloid‐lowering immunotherapies in Alzheimer's disease based on clearcut biomarker evidence

Alzheimer s & Dementia(2024)10.1002/alz.14342

N/A

0.515DataRank · unranked

30 citations

Randall J. Bateman, Damian C. Crowther, Jeff Cummings, John Dwyer, Takeshi Iwatsubo +7 more

Single-subject grey matter network trajectories over the disease course of autosomal dominant Alzheimer’s disease

Brain Communications(2020)10.1093/braincomms/fcaa102

N/A

0.464DataRank · unranked

21 citations

Ellen Dicks, Guoqiao Wang, Aylin Dincer, Shaney Flores, Sarah Keefe +81 more

The behavioral variant of Alzheimer’s disease does not show a selective loss of Von Economo and phylogenetically related neurons in the anterior cingulate cortex

Alzheimer s Research & Therapy(2022)10.1186/s13195-021-00947-9

N/A

0.241DataRank · unranked

4 citations

Yolande A.L. Pijnenburg, Priya Gami‐Patel, Baayla D.C. Boon, Femke H. Bouwman, Janne M. Papma +10 more

Gray matter network properties show distinct associations with CSF p-tau 181 levels and amyloid status in individuals without dementia

Aging Brain(2022)10.1016/j.nbas.2022.100054

N/A

0.208DataRank · unranked

3 citations

Silvia Ingala, Viktor Wottschel, Alle Meije Wink, Henk Mutsaerts, Sven Haller +15 more

[ 18 F]Flortaucipir PET Across Various MAPT Mutations in Presymptomatic and Symptomatic Carriers

Neurology(2021)10.1212/wnl.0000000000012448

N/A

0DataRank · unranked

51 citations

Janne M. Papma, Sander C.J. Verfaillie, Denise Visser, Emma Weltings, Colin Groot +20 more

Heterogeneous distribution of tau pathology in the behavioural variant of Alzheimer’s disease

Journal of Neurology Neurosurgery & Psychiatry(2021)10.1136/jnnp-2020-325497

N/A

0DataRank · unranked

34 citations

Oskar Hansson, Yolande A.L. Pijnenburg, Renaud La Joie, William G. Mantyh, Pontus Tideman +24 more

Four subgroups based on tau levels in Alzheimer’s disease observed in two independent cohorts

Alzheimer s Research & Therapy(2021)10.1186/s13195-020-00713-3

N/A

0DataRank · unranked

33 citations

Flora H. Duits, Kirsten E. J. Wesenhagen, Laura L. Ekblad, Emma E. Wolters, Eline A.J. Willemse +6 more

Sex-specific metabolic pathways associate with Alzheimer’s Disease (AD) endophenotypes in the European Medical Information Framework for AD Multimodal Biomarker Discovery cohort

medRxiv(2021)10.1101/2021.04.06.21254535

N/A

0DataRank · unranked

0 citations

Rebecca Green, Min Kim, Jodie Lord, Amera A. Ebshiana, Sarah Westwood +45 more

Rare variants in IFFO1, DTNB, NLRC3 and SLC22A10 associate with Alzheimer’s disease CSF profile of neuronal injury and inflammation

Molecular Psychiatry(2022)10.1038/s41380-022-01437-6

N/A

0DataRank · unranked

25 citations

Fahri Küçükali, Isabelle Bos, Stephanie J. B. Vos, Sebastiaan Engelborghs, Tim De Pooter +35 more

Determining the Minimal Important Change of Everyday Functioning in Dementia

Neurology(2022)10.1212/wnl.0000000000200781

N/A

0DataRank · unranked

22 citations

Merike Verrijp, Caroline B. Terwee, Roos J. Jutten, Merel C. Postema, Frederik Barkhof +8 more

Plasma biomarkers predict amyloid pathology in cognitively normal monozygotic twins after 10 years

Brain Communications(2022)10.1093/braincomms/fcad024

N/A

0DataRank · unranked

9 citations

Inge M.W. Verberk, Jori Tomassen, Ben den Dulk, Erik Stoops, Jeffrey L. Dage +10 more

Giving meaning to the scores of the Amsterdam instrumental activities of daily living questionnaire: a qualitative study

Health and Quality of Life Outcomes(2022)10.1186/s12955-022-01958-2

N/A

0DataRank · unranked

14 citations

Caroline B. Terwee, Merike Verrijp, Leonie N.C. Visser, Philip Scheltens, Sietske A.M. Sikkes +1 more

Multivariate GWAS of Alzheimer’s disease CSF biomarker profiles implies GRIN2D in synaptic functioning

medRxiv(2022)10.1101/2022.08.02.22278185

N/A

0DataRank · unranked

4 citations

Olena Ohlei, Fahri Küçükali, Isabelle Bos, Stephanie J. B. Vos, Dmitry Prokopenko +33 more

Left-handedness, learning disability, autoimmune disease, and seizure history influence age at onset and phenotypical targeting of Alzheimer’s disease

medRxiv(2022)10.1101/2022.12.17.22283307

N/A

0DataRank · unranked

4 citations

Rik Ossenkoppele, Neill R. Graff‐Radford, Isabel Elaine Allen, Wendy Shwe, Lynne Rosenberg +23 more

Dementia prevention in memory clinics: recommendations from the European task force for brain health services

The Lancet Regional Health - Europe(2023)10.1016/j.lanepe.2022.100576

N/A

0DataRank · unranked

181 citations

Daniele Altomare, Federica Ribaldi, Nicolas Villain, Carol Brayne, Naaheed Mukadam +38 more

Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup

Alzheimer s & Dementia(2024)10.1002/alz.13859

N/A

0DataRank · unranked

2346 citations

J. Scott Andrews, Thomas G. Beach, Teresa Buracchio, Billy Dunn, Ana Graf +15 more

Blood‐based multivariate methylation risk score for cognitive impairment and dementia

Alzheimer s & Dementia(2024)10.1002/alz.14061

N/A

0DataRank · unranked

17 citations

Rachel Cavill, Rick A. Reijnders, Joshua Harvey, Jan Homann, Morteza Kouhsar +52 more

Blood DNA methylomic signatures associated with CSF biomarkers of Alzheimer's disease in the EMIF‐AD study

Alzheimer s & Dementia(2024)10.1002/alz.14098

N/A

0DataRank · unranked

16 citations

Ehsan Pishva, Morteza Kouhsar, Jennifer Imm, Valerija Dobričić, Peter Johannsen +35 more

A Pilot Electroencephalography Study of the Effect of CT1812 Treatment on Synaptic Activity in Patients with Mild to Moderate Alzheimer's Disease

The Journal of Prevention of Alzheimer s Disease(2024)10.14283/jpad.2024.154

N/A

0DataRank · unranked

13 citations

Willem de Haan, E. Scheijbeler, Madison Hamby, Stefania Catalano, Philip Scheltens +3 more

Axonal damage and inflammation response are biological correlates of decline in small-world values: a cohort study in autosomal dominant Alzheimer’s disease

Brain Communications(2024)10.1093/braincomms/fcae357

N/A

0DataRank · unranked

3 citations

Courtney L. Sutphen, Ellen Dicks, Diederick M de Leeuw, Ricardo Allegri, Sarah Berman +33 more

Clinical criteria for limbic‐predominant age‐related TDP‐43 encephalopathy

Alzheimer s & Dementia(2025)10.1002/alz.14202

N/A

0DataRank · unranked

73 citations

Peter T. Nelson, Liana G. Apostolova, Konstantinos Arfanakis, Patricia A. Boyle, Cynthia M. Carlsson +32 more

Enlarged cavum septum pellucidum as a neuroimaging signature of head impact exposure

Brain Communications(2025)10.1093/braincomms/fcaf085

N/A

0DataRank · unranked

6 citations

Hugo L. Hempel, Suzan van Amerongen, Hannah de Bruin, Fleur H C van der Linden, Vikram Venkatraghavan +7 more

Synaptic protein CSF levels relate to memory scores in individuals without dementia

Alzheimer s Research & Therapy(2025)10.1186/s13195-025-01703-z

N/A

0DataRank · unranked

5 citations

Diederick Martijn de Leeuw, Jori Tomassen, Johan Gobom, Isabelle Bos, Stephanie J. B. Vos +21 more

Characterizing visual read tau‐PET‐negative participants with Alzheimer's disease dementia

Alzheimer s & Dementia(2025)10.1002/alz.14423

N/A

0DataRank · unranked

1 citations

Emma M. Coomans, Lotte A. de Koning, Denise Visser, Eline Neutelings, Anouk den Braber +13 more

Associations of lifestyle factors with amyloid pathology in persons without dementia

Journal of Alzheimer s Disease(2025)10.1177/13872877251379083

N/A

0DataRank · unranked

0 citations

Stephanie J. B. Vos, Nancy N. Maserejian, Mercè Boada, Mira Didic, Sebastiaan Engelborghs +95 more

Blood DNA methylomic signatures associated with CSF biomarkers of Alzheimer’s disease in the EMIF‐AD Multimodal Biomarker Discovery study

Alzheimer's & Dementia(2023)10.1002/alz.080072

N/A

0DataRank · unranked

0 citations

Jennifer L Imm, Valerija Dobricic, Yasmine Sommerer, Isabelle Bos, Stephanie J. B. Vos +26 more

Neurodevelopment and neural environment inform Alzheimer's disease age at onset and phenotype

Alzheimer s & Dementia(2025)10.1002/alz.70668

N/A

0DataRank · unranked

5 citations

Rik Ossenkoppele, Neill R. Graff‐Radford, Isabel Elaine Allen, Wendy Shwe, Lynne Rosenberg +23 more

Pathophysiological subtypes of Alzheimer’s disease based on cerebrospinal fluid proteomics

Brain(2020)10.1093/brain/awaa325

N/A

0DataRank · unranked

224 citations

Johan Gobom, Lianne M. Reus, Iris E. Jansen, Shengjun Hong, Valerija Dobričić +23 more

Genome-wide association study of Alzheimer’s disease CSF biomarkers in the EMIF-AD Multimodal Biomarker Discovery dataset

Translational Psychiatry(2020)10.1038/s41398-020-01074-z

N/A

0DataRank · unranked

76 citations

Dmitry Prokopenko, Valerija Dobričić, Fabian Kilpert, Isabelle Bos, Stephanie J. B. Vos +41 more

Identifying Sensitive Measures of Cognitive Decline at Different Clinical Stages of Alzheimer’s Disease

Journal of the International Neuropsychological Society(2020)10.1017/s1355617720000934

N/A

0DataRank · unranked

67 citations

Sietske A.M. Sikkes, Rebecca E. Amariglio, Rachel F. Buckley, Michael J Properzi, Gad A. Marshall +10 more

APOE ε4 genotype-dependent cerebrospinal fluid proteomic signatures in Alzheimer’s disease

Alzheimer s Research & Therapy(2020)10.1186/s13195-020-00628-z

N/A

0DataRank · unranked

55 citations

Betty M. Tijms, Johan Gobom, Valerija Dobričić, Isabelle Bos, Stephanie J. B. Vos +18 more

Grey matter network trajectories across the Alzheimer’s disease continuum and relation to cognition

Brain Communications(2020)10.1093/braincomms/fcaa177

N/A

0DataRank · unranked

20 citations

Lisa Vermunt, Wiesje M. van der Flier, Frederik Barkhof, Philip Scheltens, Betty M. Tijms +2 more

Amyloid-β CSF/PET discordance vs tau load 5 years later: It takes two to tangle

medRxiv(2020)10.1101/2020.01.29.20019539

N/A

0DataRank · unranked

5 citations

Lyduine E. Collij, Philip Scheltens, Femke H. Bouwman, Rik Ossenkoppele, for the Alzheimer’s Disease Neuroimaging Initiative +1 more

Cerebrospinal fluid total tau levels indicate aberrant neuronal plasticity in Alzheimer’s disease

medRxiv(2020)10.1101/2020.10.29.20211920

N/A

0DataRank · unranked

3 citations

Lianne M. Reus, Johan Gobom, Iris E. Jansen, Ellen Dicks, Magda Tsolaki +25 more

Tau PET correlates with different Alzheimer’s disease‐related features compared to CSF and plasma p‐tau biomarkers

EMBO Molecular Medicine(2021)10.15252/emmm.202114398

N/A

0DataRank · unranked

133 citations

Juhan Reimand, Ruben Smith, Antoine Leuzy, Olof Strandberg, Sebastian Palmqvist +11 more

Modifiable risk factors for dementia and dementia risk profiling. A user manual for Brain Health Services—part 2 of 6

Alzheimer s Research & Therapy(2021)10.1186/s13195-021-00895-4

N/A

0DataRank · unranked

108 citations

Timothy Rittman, Shabina Hayat, Carol Brayne, Frank Jessen, Kaj Blennow +38 more

Characteristics of subjective cognitive decline associated with amyloid positivity

Alzheimer s & Dementia(2021)10.1002/alz.12512

N/A

0DataRank · unranked

54 citations

Willemijn J. Jansen, Stephanie J. B. Vos, Mercè Boada, Lucilla Parnetti, Tomasz Gabryelewicz +58 more

Philip Scheltens

Indexed papers

Top data-sharing exemplar

Papers